Bradley McGregor
Dana-Farber Cancer Institute

Last Updated On 2/2/2024 9:28:52 PM
This is a disclosure report of the user financial relationships with for-profit health care companies.
All relationships are considered compensated unless otherwise noted. Relationships are self-held unless otherwise noted.

Employment
No Relationships to Disclose

Leadership
No Relationships to Disclose

Stock and Other Ownership Interests
No Relationships to Disclose

Honoraria
No Relationships to Disclose

Consulting or Advisory Role
Company: Seattle Genetics/Astellas
Recipient: You
Company: Exelixis
Recipient: You
Company: Astellas Pharma
Recipient: You
Company: Pfizer
Recipient: You
Company: Eisai
Recipient: You
Company: Bristol-Myers Squibb
Recipient: You
Company: Gilead Sciences
Recipient: You
Company: Arcus Biosciences
Recipient: You
Company: Loxo/Lilly
Recipient: You

Speakers' Bureau
No Relationships to Disclose

Research Funding
Company: Bristol-Myers Squibb
Recipient: Your Institution
Company: Exelixis
Recipient: Your Institution
Company: Calithera Biosciences
Recipient: Your Institution
Company: Seattle Genetics/Astellas
Recipient: Your Institution
Company: Pfizer/EMD Serono
Recipient: Your Institution

Patents, Royalties, Other Intellectual Property
No Relationships to Disclose

Expert Testimony
No Relationships to Disclose

Travel, Accommodations, Expenses
No Relationships to Disclose

Other Relationship
No Relationships to Disclose

(OPTIONAL) Uncompensated Relationships
No Relationships to Disclose

(OPTIONAL) Open Payments Link
not answered